Evidence map›Paper›PMID 30912763›Full record

ArticleAging2019

H

Yuanzhou Zhang, Jun Gao, Weiming Sun, Xin Wen, Yuxin Xi, Yuehong Wang, Can Wei, Changqing Xu, Hongzhu Li

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases.Oxidative medicine and cellular longevity · 2021
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuanzhou Zhang *Department of Pathophysiology, Harbin Medical University, Harbin, China.
Jun Gao *Department of Osteology, the First Hospital of Harbin, Harbin, China.
Weiming SunDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Xin WenDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Yuxin XiDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Yuehong WangDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Can WeiDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Changqing XuDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Hongzhu LiDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen sulfide (H

Indexed as

Ischemic PostconditioningAnimalsApoptosisHeparin-binding EGF-like Growth FactorHydrogen SulfideMyocytes, CardiacSignal TransductionUp-RegulationHeparin-binding EGF-like Growth FactorHydrogen Sulfideaged cardiomyocytesH9C2 cellsHB-EGF/EGFR pathwayhydrogen sulfidepost-conditioning

Identifiers

PMID30912763
PMCPMC6461169
OpenAlexW2924176505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.